Mallory Hackett

By Mallory Hackett 02:40 pm June 22, 2020
Nearly 90% of people managing chronic conditions in the U.S. surveyed for Sony’s mSafety Wearable Platform Division said they could better manage their conditions with remote monitoring. The study was published in time for the American Telemedicine Association's virtual conference today. It looked at the rate of adoption and interest in remote health-monitoring technology targeted at people...
By Mallory Hackett 02:57 pm June 18, 2020
AARP Innovation Labs announced the winners of its Hacking Menopause Challenge, which aimed to create noninvasive tools to combat common menopause symptoms, such as hot flashes, fatigue and sleep disorders. EloCare won the top prize of $5,000 for the best two-system solution. Pride Chill and NYX Systems each collected $4,000 for the best one-system solution and the best retail-directed one-system...
By Mallory Hackett 02:10 pm June 17, 2020
New research out of Australia published in the Journal of Medical Internet Research indicates that individuals living during the coronavirus pandemic had significantly worse mental health outcomes than their peers measured before the pandemic. The study used an online mental health-measurement platform to compare the mental health of people before and during the pandemic. Researchers also looked...
By Mallory Hackett 01:42 pm June 17, 2020
Augmedics, a developer of augmented reality surgical image guidance tools, raised $15 million in Series B funding, led by its U.S. staff. In this nearly unheard of money-raising strategy, the company’s employees formed AUG Management LLC, a limited liability company, and raised $4 million. The remainder of the funds came from existing shareholders AO Invest and Terralab Ventures, and undisclosed...
By Mallory Hackett 03:42 pm June 16, 2020
This morning BioIQ, a health-testing and biometric-screening technology company, released its at-home COVID-19, Flu A/Flu B, and 21 Test Respiratory Panel saliva test. The company partnered with P23 labs, which already scored an emergency use authorization (EUA) from the FDA for its at-home saliva COVID-19 test kits. Currently, the test is being targeted towards employees, health plan members,...
By Mallory Hackett 02:59 pm June 12, 2020
Conversa Health, an automated virtual care communication platform, closed $12 million in a Series B funding this week. The round was co-led by Builders VC and Northwell Ventures and included investments from  P5 Health Ventures, Nassau Street Ventures and UH Ventures. With this, Conversa has raised more than $26 million in funding. WHAT THEY DO Conversa partners with health systems to virtually...
By Mallory Hackett 12:24 pm June 12, 2020
Kyruus, a provider search and scheduling tool for health systems, announced yesterday that it has garnered $30 million in funding from Francisco Partners. In late December, Kyruus scored $42 million in Series D funding. With this new investment, the company’s total funding is over $155 million. WHAT THEY DO Kyruus delivers search and scheduling to let health systems connect patients with the best...
By Mallory Hackett 01:46 pm June 11, 2020
RapidSOS received $21 million in funding, the emergency response technology company announced today. The funding round was led by Transformation Capital and included support from C5 Capital, Laerdal Million Lives Fund and existing investors.  WHAT THEY DO The New York-based company developed its digital platform to provide free critical data to first responders in order to make faster and smarter...
By Mallory Hackett 11:36 am June 10, 2020
Since the beginning of the COVID-19 pandemic, healthcare companies have had to develop new ways of delivering care. But one aspect has remained constant: having effective digital tools is critical in order to make it to the future. Even though the importance of digital strategies is not a new concept, it has taken on whole new meaning now that healthcare providers have become more reliant on them...
By Mallory Hackett 09:54 am June 9, 2020
A new study published in US Endocrinology found Abbott’s continuous glucose monitoring system, the FreeStyle Libre, demonstrated significant cost savings for diabetic care compared to traditional fingerstick testing.  Abbott’s system uses flash continuous glucose monitoring (CGM) through a sensor placed to the back of the upper arm, and lasts for up to 14 days. The device automatically collects...